Fuda Cancer Hospital
Bladder cancer treatment cost in China typically depends on the disease stage and required surgical intervention. Key procedures like bladder removal with reconstruction ranges from $24,000 to $48,500, while a standard bladder removal costs $19,500 to $41,000. Expenses are influenced by hospital tier and treatment complexity, often providing 40-60% savings compared to the US. Top cities for oncology include Guangzhou and Xiamen.
Typical Bladder Cancer Treatment Costs in China
Bookimed Expert Insight: Patients with advanced or late-stage cancer benefit most from multidisciplinary centers offering specialized technologies. Fuda Cancer Hospital is a JCI-accredited facility focusing on minimally invasive cryosurgery and NanoKnife therapies. For those seeking innovative protocols, Xiamen Humanity Hospital provides access to Phase I–IV drug trials. These specialized institutions offer high-value care for complex cases that standard hospitals may not handle.
| China | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $11,500 | from $7,000 | from $12,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $22,500 | from $22,500 | from $40,000 |
| Chemotherapy for breast cancer | from $14,800 | from $1,200 | from $15,000 |
| Bladder removal with reconstruction | from $24,000 | from $15,000 | from $32,000 |
| Bladder removal | from $19,500 | from $8,000 | from $22,000 |
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.
Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
Chinese oncology centers maintain international standards through Joint Commission International (JCI) accreditation. Facilities like Fuda Cancer Hospital in Guangzhou are JCI-accredited. These centers treat bladder cancer using advanced technologies. These include NanoKnife, cryosurgery, and immunotherapy drugs like Keytruda or Padcev.
Bookimed Expert Insight: While China has over 1,000,000 annual patients at major tertiary hospitals, only around 20 facilities hold JCI accreditation. Patients should look for specific oncology specializations in these JCI centers. For example, Fuda Cancer Hospital focuses specifically on late-stage cases with high-tech ablation tools.
Patient Consensus: Patients note that private JCI-accredited hospitals offer better hygiene and English-speaking staff. Many suggest hiring a private translator if choosing a large public university hospital in Shanghai.
Bladder cancer surgery in China achieves an overall 5-year survival rate of approximately 71.5%. Outcomes reach 86.4% for early-stage patients treated with transurethral resection. Specialized tertiary centers report even higher survival rates near 74% due to advanced minimally invasive techniques and integrated oncological care.
Bookimed Expert Insight: Choosing JCI-accredited facilities like Fuda Cancer Hospital provides access to specialized technologies like NanoKnife and cryosurgery. These clinics often manage higher patient volumes, with Xiamen Humanity Hospital serving 1,000,000 patients annually. Large-scale surgical experience at these centers typically correlates with better proficiency in complex bladder reconstructions.
Patient Consensus: Patients note that seeking treatment at top-tier hospitals in major cities significantly improves cure rates compared to regional clinics. Many emphasize that while robotic surgery options at private wings are more expensive, they offer better peace of mind regarding long-term recurrence.
Robotic and laparoscopic cystectomy are routinely available at major Chinese oncology centers. These minimally invasive methods significantly reduce intraoperative blood loss and lower transfusion rates. Patients often experience shorter hospital stays and faster physical recovery compared to traditional open surgery approaches.
Bookimed Expert Insight: Patient volume is the most critical safety indicator in China. Fuda Cancer Hospital serves over 30,000 international patients and specializes in over 10 types of minimally invasive therapies. Xiamen Humanity Hospital manages 1,000,000 patients annually as a major tertiary center. High-volume centers often provide more consistent outcomes for complex robotic bladder reconstructions.
Patient Consensus: Patients note that while open surgery remains common, robotic options are preferred for significantly lower transfusion risks. Many emphasize asking surgeons about their specific annual case volume to ensure the highest safety levels.
Travelers from China should wait 2 to 4 weeks after major bladder surgery before flying. Minor procedures like cystoscopy may allow travel after 3 to 5 days. International patients must receive medical clearance from their surgeon. This timeline prevents blood clots and ensures safe healing at high altitudes.
Bookimed Expert Insight: While major centers like Xiamen Humanity Hospital serve 1,000,000 patients annually, individual recovery times vary. Fuda Cancer Hospital provides specialized minimally invasive options like NanoKnife and cryosurgery. These advanced techniques may reduce hospital stays. However, long-haul travel from China still requires strict adherence to the 14-day minimum. This timeframe prioritizes stability over early departure.
Patient Consensus: Patients note that cabin pressure can trigger bladder spasms weeks later. Many emphasize wearing compression socks and walking every hour during long-haul flights from China.
In-country stays for bladder cancer treatment in China typically range from 1 to 12 days. Transurethral resection (TURBT) often allows same-day discharge or a 1-night stay. Complex procedures like radical cystectomy with reconstruction require 5 to 12 days in JCI-accredited hospitals.
Bookimed Expert Insight: China's high-volume oncology centers show a pattern of rapid post-operative turnover. Fuda Cancer Hospital manages over 30,000 international patients using minimally invasive techniques. These specialized therapies often reduce the typical 10-day surgical recovery to just 3 days. Patients should choose centers with JCI accreditation to ensure these shorter stays meet international safety standards.
Patient Consensus: Patients note it is important to plan for 2 to 3 weeks total in-country. This time covers the hospital stay plus outpatient follow-ups and visa logistics for a safe return home.
Minimally invasive bladder surgery in China typically leaves 2 to 6 small, discreet scars. These keyhole incisions measure between 5 and 12 millimeters. Most scars fade significantly within 6 to 12 months. They often become thin, pale lines that are barely visible to the naked eye.
Bookimed Expert Insight: Data from high-volume centers like Xiamen Humanity Hospital, which serves 1,000,000 patients annually, shows that surgical volume correlates with aesthetic outcomes. Specialized oncology centers in Guangzhou often prioritize multi-modal therapies over large-scale open surgeries. This focus on lung and bladder preservation frequently results in smaller, strategically placed ports that mature faster than standard laparoscopic incisions.
Patient Consensus: Patients note that 2 years after robotic surgery, small port scars often look like tiny freckles that no one notices. Many emphasize that keeping incisions covered from the sun for the first year is vital for preventing permanent darkening.
Guangzhou, Beijing, and Shanghai host Chinas highest volume bladder cancer programs for international patients. These hubs feature JCI-accredited centers using advanced cryosurgery and NanoKnife technologies. Facilities like Fuda Cancer Hospital in Guangzhou have treated over 30,000 international patients from 100 countries.
Bookimed Expert Insight: While Beijing and Shanghai are recognized for academic research, Guangzhou emerges as the practical leader for international accessibility. Fuda Cancer Hospital stands out because nearly 50% of its patient base is international. This high volume suggests better-established support systems for non-residents compared to general tertiary hospitals.
Patient Consensus: Patients note that while Beijing hospitals handle high caseloads, coordination can be complex. Many suggest hiring an independent translator to ensure staging reports and scans are clearly understood.
Chinese hospitals provide surgical and medical options for bladder cancer. These include robotic-assisted radical cystectomy and precision radiotherapy. Specialist centres like JCI-accredited Fuda Cancer Hospital offer minimally invasive alternatives like NanoKnife and cryosurgery. Treatment plans often combine chemotherapy, immunotherapy with Keytruda, and nuclear medicine.
Bookimed Expert Insight: Chinese oncology centres such as Xiamen Humanity Hospital operate as massive research hubs. They serve 1,000,000 patients annually. This volume allows doctors like Professor Liu Shi Xin to gain experience with rare cases. These hospitals often provide clinical trials for therapies like Boron Neutron Capture Therapy. These may be available here before they reach Australian clinics.
China provides radiotherapy for bladder cancer, including proton and carbon ion therapy. Active centres in Shanghai and Guangzhou treat deep-seated tumours with precision. These facilities use systems like Varian ProBeam to target cancer cells while sparing healthy tissue.
Bookimed Expert Insight: While proton therapy is widely discussed, China has established its first Boron Neutron Capture Therapy (BNCT) centre. This facility is located at Xiamen Humanity Hospital. This is a significant alternative for patients seeking particle-based treatments. For bladder cancer, this infrastructure suggests a high degree of specialisation in physics-based oncology.
Fuda Cancer Hospital in Guangzhou and Xiamen Humanity Hospital are key centres for bladder cancer in China. These facilities specialise in oncology, offering minimally invasive options and robotic surgery. They maintain international standards with JCI accreditation and serve patients from over 100 countries.
Bookimed Expert Insight: Many hospitals focus on standard surgery. However, Fuda Cancer Hospital stands out for its high volume of international patients. It has treated over 30,000 people from 100 countries. This suggests their staff are comfortable with the specific logistics Australian patients need.
International departments in Chinese hospitals bridge linguistic and administrative gaps for foreign patients. Dedicated desks coordinate hospital navigation, medical translation, and visa documentation. Many top-tier centres, such as Fuda Cancer Hospital, hold Joint Commission International accreditation for safety standards that meet global expectations.
Bookimed Expert Insight: While many tertiary centres handle high volumes, Xiamen Humanity Hospital stands out. They integrate technologies like the Da Vinci Surgical System and intraoperative MRI within their workflow. Patients should look for hospitals that manage over 30,000 international cases. These facilities typically have the most established logistical support systems.
Patient Consensus: Support services in China act as essential end-to-end coordinators for travel logistics and directions. Patients recommend contacting international desks before arrival to help streamline specialist pathways. They also suggest keeping physical copies of records for clear communication during multidisciplinary reviews.
Foreign patients can participate in oncology clinical trials in China. The country is a leader in cancer research. In 2024, 39% of all trials focused on oncology. Regulatory reviews now take roughly 60 days. This makes trial starts more efficient for international patients.
Bookimed Expert Insight: Many countries focus on early-stage research. However, Chinese centres like Xiamen Humanity Hospital are accredited for all stages from Phase I through Phase IV. This is significant for bladder cancer patients. It means access to both experimental safety studies and large-scale efficacy trials exists in one location.
Patient Consensus: Patients note that access to trials depends on the hospital and trial sponsor. Most find that high-end public hospitals in major cities provide the most reliable path for non-Chinese passport holders.
Chinese specialist hospitals accept international health insurance for bladder cancer treatment. JCI-accredited facilities in Guangzhou and Xiamen often provide direct billing for global providers. Patients can access specialised care like NanoKnife and immunotherapy. Documentation is usually translated to assist with reimbursement claims.
Bookimed Expert Insight: Many patients focus on Beijing, but Guangzhou is a major hub for international oncology. Fuda Cancer Hospital has treated patients from over 100 countries. Their experience with international insurance paperwork is extensive. This often makes the billing process smoother for Australians than at public hospitals.